#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	3840	16S	1529	1529	99.87	16S.l6.c4.ctg.1	2386	477.1	0	.	n	.	0	A662G	SNP	662	662	A	1020	1020	G	579	G	490	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	3840	16S	1529	1529	99.87	16S.l6.c4.ctg.1	2386	477.1	0	.	n	.	0	C1450T	SNP	1450	1450	C	1808	1808	T	560	T,G	521,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	3840	16S	1529	1529	99.87	16S.l6.c4.ctg.1	2386	477.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1542	1542	C	544	C	482	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6146	23S	2890	2890	99.9	23S.l6.c17.ctg.1	3813	482.7	0	.	n	.	0	T695C	SNP	695	695	T	1138	1138	C	477	C,T,A	319,103,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6146	23S	2890	2890	99.9	23S.l6.c17.ctg.1	3813	482.7	0	.	n	.	0	C709T	SNP	709	709	C	1152	1152	T	471	T,C	323,101	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6146	23S	2890	2890	99.9	23S.l6.c17.ctg.1	3813	482.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2414	2414	C	544	C	477	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6146	23S	2890	2890	99.9	23S.l6.c17.ctg.1	3813	482.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2488	2488	A	574	A	497	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6146	23S	2890	2890	99.9	23S.l6.c17.ctg.1	3813	482.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	3040	3040	C	538	C,T,A	440,3,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6146	23S	2890	2890	99.9	23S.l6.c17.ctg.1	3813	482.7	0	HET	.	.	.	G262A,T	.	262	262	G	705	705	G	600	G,A,T	378,126,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	6146	23S	2890	2890	99.9	23S.l6.c17.ctg.1	3813	482.7	0	HET	.	.	.	G1337A	.	1337	1337	G	1780	1780	G	546	G,A	367,119	.	.
folP.WHO_W_01420c	folP.WHO_W_01420c	1	1	539	578	folP	852	852	99.77	folP.l15.c4.ctg.1	1799	96.3	0	.	p	.	0	S68P	NONSYN	202	204	TCG	670	672	CCG	137;137;137	C;C,G;G,A	121;120,1;117,1	.	.
folP.WHO_W_01420c	folP.WHO_W_01420c	1	1	539	578	folP	852	852	99.77	folP.l15.c4.ctg.1	1799	96.3	0	.	p	.	0	A204V	NONSYN	610	612	GCA	1078	1080	GTA	113;113;111	G;T;A	101;98;100	.	.
folP.WHO_W_01420c	folP.WHO_W_01420c	1	1	539	578	folP	852	852	99.77	folP.l15.c4.ctg.1	1799	96.3	1	SNP	p	R228S	1	.	.	682	684	AGC	1150	1152	AGC	118;119;119	A;G;C	99;100;99	folP.WHO_W_01420c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1374	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3751	109.9	1	SNP	p	S91F	0	.	.	271	273	TCC	755	757	TCC	123;123;123	T;C;C	116;117;116	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1374	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3751	109.9	1	SNP	p	D95G	0	.	.	283	285	GAC	767	769	GAC	123;124;124	G;A;C	116;117;117	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1374	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3751	109.9	1	SNP	p	D95N	0	.	.	283	285	GAC	767	769	GAC	123;124;124	G;A;C	116;117;117	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	27	530	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1575	100.6	1	SNP	p	G45D	0	.	.	133	135	GGC	593	595	GGC	158;156;154	G;G;C	140;138;136	mtrR.WHO_F_01564:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	372	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1538	72.6	0	.	n	.	0	.206T	INS	206	206	T	973	973	T	154	T	128	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	1322	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3272	121.2	0	.	p	.	0	G459S	NONSYN	1375	1377	GGT	1885	1887	AGT	154;154;154	A;G;T	130;130;132	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	1322	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3272	121.2	1	SNP	p	D86N	0	.	.	256	258	GAC	766	768	GAC	150;149;150	G;A;C	125;127;129	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	1322	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3272	121.2	1	SNP	p	S87R	0	.	.	259	261	AGT	769	771	AGT	150;150;150	A;G;T	130;131;128	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	1322	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3272	121.2	1	SNP	p	S87I	0	.	.	259	261	AGT	769	771	AGT	150;150;150	A;G;T	130;131;128	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	1322	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3272	121.2	1	SNP	p	S87W	0	.	.	259	261	AGT	769	771	AGT	150;150;150	A;G;T	130;131;128	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	1322	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3272	121.2	1	SNP	p	S88P	0	.	.	262	264	TCC	772	774	TCC	150;152;151	T;C;C	125;131;128	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1102	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3018	109.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1733	1735	GGC	147;147;147	G;G;C	124;127;126	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.001	penA.22.001	1	1	27	978	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2735	107.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1377	1379	GCA	146;145;145	G;C,G;A	123;120,1;121	penA.22.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	978	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2735	107.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1380	1382	ATC	145;145;146	A;T;C	123;124;122	penA.22.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	978	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2735	107.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1392	1394	GTG	148;148;149	G;T;G	123;124;126	penA.22.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	978	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2735	107.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1392	1394	GTG	148;148;149	G;T;G	123;124;126	penA.22.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	978	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2735	107.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1896	1898	ACC	121;122;122	A;C;C	104;105;108	penA.22.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	978	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2735	107.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1950	1952	GCG	122;122;121	G,A;C;G,C	106,1;92;99,1	penA.22.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	978	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2735	107.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1950	1952	GCG	122;122;121	G,A;C;G,C	106,1;92;99,1	penA.22.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	978	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2735	107.0	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2073	2075	GGT	128;128;128	G;G;T	107;108;101	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	978	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2735	107.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2082	2084	GGC	127;126;126	G;G,T;C	102;106,1;109	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	978	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2735	107.0	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2100	2102	CCG	122;122;124	C,G;C,G,A;G,C	102,1;108,1,1;102,1	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	1282	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3441	111.7	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1778	1780	CTG	106;105;106	C;T;G	87;87;86	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	660	porA	1146	1146	99.56	porA.l15.c4.ctg.1	2142	92.6	0	.	p	.	0	S22G	NONSYN	64	66	AGC	549	551	GGC	115;116;116	G;G;C	100;100;101	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	660	porA	1146	1146	99.56	porA.l15.c4.ctg.1	2142	92.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	731	731	C	126	C	105	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	114	porB1a	984	177	90.06	porB1a.l15.c4.ctg.1	1374	24.6	0	.	p	.	0	H217N	NONSYN	649	651	CAT	1222	1224	AAT	8;8;7	A;A;T	8;8;7	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	114	porB1a	984	177	90.06	porB1a.l15.c4.ctg.1	1374	24.6	0	.	p	.	0	D218N	NONSYN	652	654	GAT	1225	1227	AAT	7;7;7	A;A;T	7;7;7	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	114	porB1a	984	177	90.06	porB1a.l15.c4.ctg.1	1374	24.6	0	.	p	.	0	A222V	NONSYN	664	666	GCT	1237	1239	GTT	8;8;8	G;T;T	7;7;7	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	114	porB1a	984	177	90.06	porB1a.l15.c4.ctg.1	1374	24.6	0	.	p	.	0	V226A	NONSYN	676	678	GTA	1249	1251	GCA	7;7;6	G;C;A	6;6;5	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	114	porB1a	984	177	90.06	porB1a.l15.c4.ctg.1	1374	24.6	0	.	p	.	0	.	MULTIPLE	700	702	ACT	1272	1274	GTA	6;6;6	G;T;A	5;5;5	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	114	porB1a	984	177	90.06	porB1a.l15.c4.ctg.1	1374	24.6	0	.	p	.	0	D238fs	FSHIFT	712	712	G	1284	1284	G	5	G	4	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	856	porB1b	1047	1047	98.38	porB1b.l15.c30.ctg.1	1785	141.1	0	.	p	.	0	T18M	NONSYN	52	54	ACG	488	490	ATG	186;186;187	A,G;T;G	156,1;156;159	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	856	porB1b	1047	1047	98.38	porB1b.l15.c30.ctg.1	1785	141.1	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	863	865	CAA	149;150;150	C;A;A	128;128;129	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	856	porB1b	1047	1047	98.38	porB1b.l15.c30.ctg.1	1785	141.1	0	.	p	.	0	E212D	NONSYN	634	636	GAA	1070	1072	GAT	138;139;139	G;A;T	124;126;123	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	856	porB1b	1047	1047	98.38	porB1b.l15.c30.ctg.1	1785	141.1	0	.	p	.	0	H213G	NONSYN	637	639	CAT	1073	1075	GGT	139;139;139	G,T;G;T	124,1;123;125	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	856	porB1b	1047	1047	98.38	porB1b.l15.c30.ctg.1	1785	141.1	0	.	p	.	0	V215A	NONSYN	643	645	GTT	1079	1081	GCT	141;141;142	G;C;T	123;128;128	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	856	porB1b	1047	1047	98.38	porB1b.l15.c30.ctg.1	1785	141.1	0	.	p	.	0	S220T	NONSYN	658	660	AGC	1094	1096	ACT	145;145;145	A;C;T	130;130;129	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	856	porB1b	1047	1047	98.38	porB1b.l15.c30.ctg.1	1785	141.1	0	.	p	.	0	R257M	NONSYN	769	771	AGG	1205	1207	ATG	145;144;144	A;T;G	130;131;126	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	856	porB1b	1047	1047	98.38	porB1b.l15.c30.ctg.1	1785	141.1	0	.	p	.	0	R258S	NONSYN	772	774	AGG	1208	1210	AGC	145;146;146	A;G;C	130;131;131	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	856	porB1b	1047	1047	98.38	porB1b.l15.c30.ctg.1	1785	141.1	0	.	p	.	0	A259S	NONSYN	775	777	GCT	1211	1213	AGT	148;148;146	A;G;T	132;136;133	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	856	porB1b	1047	1047	98.38	porB1b.l15.c30.ctg.1	1785	141.1	0	.	p	.	0	D297N	NONSYN	889	891	GAC	1325	1327	AAC	172;173;173	A;A;C	146;148;144	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	856	porB1b	1047	1047	98.38	porB1b.l15.c30.ctg.1	1785	141.1	1	SNP	p	G120K	0	.	.	358	360	GGC	794	796	GGC	160;159;159	G;G;C	146;140;140	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	2430	rpoB	4179	4179	100.0	rpoB.l6.c4.ctg.1	5185	140.5	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2185	2187	CAT	121;123;123	C;A;T	110;114;111	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	430	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1284	100.6	1	SNP	p	V57M	1	.	.	169	171	ATG	657	659	ATG	160;161;161	A;T;G	138;143;143	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
